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Plasma and tissue concentrations of warfarin in the rat were measured as a fianction of time following 
a 10 mg/kg intravenous dose. The mathematical interpretation of the experimental results sug- 
gested that the data could be explained in terms of a two-compartment open model. Following 
equilibration, which occurred within a few minutes after injection, individual tissue levels and plasma 
levels of warfarin were found to be always directly proportional. 
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tissue distribution. 
I N T R O D U C T I O N  
The purpose  of  this study was to derive a pharmacokine t ic  model  which 
would  describe the relationship between tissue and plasma concentra t ions  
of warfarin in rats, as a function of time, following an intravenous dose of  
sodium warfarin, 10 mg/kg.  
For ty  male Sprague-Dawley rats with an average weight of 300 g were 
used in the s tudy of eight time intervals:  1, 5, 15, 30, 60, 120, 180, and 240 min. 
Five animals were used for each time interval, four serving as recipients and 
the fifth as a blank. 
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EXPERIMENTAL 
Anima~ Treatment 
The rats were starved the night before the experiment and during the 
experiment; water only was allowed ad libitum. The rats were weighed in 
the morning prior to the experiment, and 3 mg of sodium warfarin was 
administered intravenously by tail vein, based on their average weight. The 
rats were not anesthetized during the injection. 
At the end of each time interval, the corresponding rats were anesthetized 
with ether U.S.P. An abdominal incision was made, and an immediate blood 
sample was taken from the bifurcation of the inferior vena cava. The needle 
was then detached and the sample transferred slowly to prevent hemolysis 
against the inside of a 17- by 100-mm plastic vial containing 0.2 ml of sodium 
citrate, 25 ~o w/v. The plasma was separated by centrifugation and transferred 
by pipette into new plastic vials, capped, and frozen at -4~ The rats were 
then decapitated, and the following were organs excised, transferred to 
plastic vials, capped, and frozen at -4~  brain, heart, lung, spleen, and 
liver. 
Tissue homogenates were prepared and then refrozen until assayed. 
Each homogenate run represented the same organ for a given time interval. 
For example, all five hearts excised at 1 min after injection were first thawed, 
blotted, and weighed, and then exactly 0.7 g of tissue from each heart was 
weighed into a separate, tared 15-ml Broeck glass tissue grinder and homog- 
enized with 7 ml of phosphate buffer, pH 7.25 (0.1 M). The homogenate was 
then transferred to glass tubes, stoppered, and frozen at -4~  until time of 
assay. 
Assay Methodology 
The amount of warfarin in plasma and tissues at various time intervals 
was determined by the modified O'Reilly method with a few modifications 
(1). The additional changes involved the extraction procedure, elimination of 
separatory funnels, and use of pyrex glass wool for filtering purposes. The 
final method is given in detail below. 
Blank rat plasma and tissue samples freshly frozen at - 4~ followed by 
thawing, homogenizing with warfarin as a spike, and refreezing at the end of 
4 months, and finally thawing again at intervals over the next 5 months, 
yielded excellent Beer's law plots. O'Reilly also reported that results of 
warfarin determinations on plasma, urine, and stool stored in the frozen 
state for several months, even when the specimens were repeatedly thawed 
and frozen, were not significantly different from those obtained on fresh 
samples (2). It was also determined that human plasma, O-positive and not 
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over 24 hr old, kept frozen for 2 weeks, gave the same blank value in the 
assay as when fresh. However, blank values were found to increase when 
the same plasma that had been kept refrigerated at 4~ was used. 
The results of calibration studies on warfarin-spiked human plasma, 
rat plasma, and rat tissues are presented in Table I. Human plasma, 4-ml 
samples, was spiked from 0.13 to 12 #g/mt; 2-ml samples were spiked from 
0.15 to 12/~g/ml. Rat plasma, 2-ml samples, was spiked from 0.25 to 7.5 #g/ml; 
rat tissues were spiked from 2 to 30/~g/g. 
Table I. Warfarin Tissue and Plasma Assay Calibration Data: 
Slopes of Least-Squares Lines Forced Through the Origin for 
Plots of Absorbance Against Amount of Warfarin in #g/ml of 
Final NaOH Solution 
Shaking 
time (min) Sample Slope" 
20 Human plasma, 4 ml 0.263 
20 Human plasma, 4 ml 0.314 
20 Human plasma, 4 ml 0.289 
20 Human plasma, 4 ml 0.282 
20 Human plasma, 4 ml 0.282 
10 Human plasma, 4 ml 0.312 
10 Human plasma, 4 ml 0.299 
10 Human plasma, 4 ml 0.299 
l0 Human plasma, 4 ml 0.329 
10 Human plasma, 4 ml 0.380 
20 Human plasma, 2 ml 0.311 
20 Human plasma, 2 ml 0.274 
20 Human plasma, 2 ml 0.265 
10 Human plasma, 2 ml 0.359 
10 Human plasma, 2 ml 0.336 
10 Rat plasma, 2 ml 0~317 
10 Rat plasma, 2 ml 0.338 
20 Rat brain homogenate, 4 ml 0.321 
20 Rat brain homogenate, 4 ml 0.289 
20 Rat heart homogenate, 4 ml 0.298 
20 Rat heart homogenate, 4 ml 0.320 
20 Rat lung homogenate, 4 ml 0.348 
20 Rat lung homogenate, 4 ml 0.327 
20 Rat spleen homogenate, 4 ml 0.303 
20 Rat spleen homogenate, 4 ml 0.328 
20 Rat liver homogenate, 4 ml 0.336 
20 Rat liver homogenate, 4 ml 0.334 
"Average slope = 0.313, which is absorbance units/#g warfarin/ml 
final NaOH (2.5 N). (Student's t test gave no significant difference 
between slopes of 10-min vs. 20-min shaking periods nor between 
slopes of 4 ml plasma, 2 ml plasma, and 4 ml tissue homogenates.) 
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The assay procedure for the determination of warfarin in rat (or human) 
plasma and tissue was as follows: 
1. Twenty milliliters of 1,2-ethylenedichloride (EDC), analytical grade, 
was pipetted into 50-ml round-bottom centrifuge tubes to receive 
teflon-lined screw caps for the given number of samples and blanks. 
2. Samples were added as follows: 
a. Human plasma: Four milliliters was layered onto EDC surface, 
and warfarin spike (#1) was added and gently distributed into 
plasma without mixing layers, followed by addition of 3 ml HC1 
(1 N). 
b. Rat plasma: Two milliliters was layered and spiked as above, 
followed by 5 ml HC1 (0.6 N). 
c. Rat tissue: Four milliliters of a uniformly dispersed 10% tissue 
homogenate, using the tissue grinder if previously prepared and 
frozen, in phosphate buffer, pH 7.25 (0.1 M), was layered as above 
onto EDC surface, and warfarin spike (ttl) was added, followed by 
3 ml HC1 (1 N). 
3. Centrifuge tubes were capped and agitated horizontally in a Kahn 
(Ebberback) shaker: 10 rain for plasma extraction, 20 min for tissue 
homogenates. Too much shaking resulted in emulsification and high 
blank values; inadequate shaking time resulted in incomplete 
transfer of warfarin into the organic phase (2). 
4. Tubes were then centrifuged at 500g, 4~ for 4 min ; the top aqueous 
layer was discarded ; 5 ml of the same phosphate buffer was added 
to remove interfering substances extracted by the relatively polar 
EDC (2); tubes were capped and agitated horizontally for 10 min 
and again centrifuged as above. 
5. The aqueous buffer was discarded; exactly 15ml of the organic 
layer was transferred to a new set of 50-ml round-bottom centrifuge 
tubes, followed by exactly 5 ml of NaOH (2.5 N) and horizontal 
agitation for 5 min. The organic layer was reduced by 10 ml with a 
pipette, and the balance including the 5-ml aqueous layer was 
filtered through pyrex glass wool into 15-ml vacutainers and cen- 
trifuged at 500g, 8 min, at room temperature. 
6. The ultraviolet absorbance of the warfarin solution was read within 
2 hr using a Gilford model 2400 spectrophotometer and 7.5-cm 
quartz cuvettes. The instrument was nulled against the blank for each 
sample reading taken at 360 and 308 nm. The net absorhance was 
then calculated by taking the difference between meter readings at 
308 and 360 nm. (The cuvettes were cleaned in 50% nitric acid for 
24hr following each assay series of 16 samples; absolute ethyl 
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alcohol was used to thoroughly dry the sample cuvette after cleaning 
between each sample reading.) 
7. The inherent absorbance of the two cuvettes, following the nitric 
acid soak, was determined by use of distilled water to be 0.005 and 
0.009. The difference between the two cuvettes was considered neg- 
ligible, and therefore a correction factor was not included in the 
calculation of the net absorbance for each sample. The 7.5-cm 
cuvettes were tagged so that one was used only for the sample, the 
other for the blank. 
8. Warfarin concentration in samples of plasma or tissue was calculated 
as follows based on a 7.5-cm pathlength : 
a. Warfarin concentration in plasma (/~g/ml) = (net A x 5 x 20)/ 
0.313 x ml of plasma x 15). 
b. Warfarin concentration in tissue (#g/g) = (net A x 5 x 20 x 1)/ 
(0.313 x 4 x 15 x 0.1) = net A/0.0188. 
Estimation of  Free (Unbound) Warfarin Plasma Concentrations 
The equation of Wosilait (3), shown as equation 1, was used for es- 
timation of free (unbound) warfarin tissue concentrations. The constants 
are those for human serum albumin, but our values of 0.9-1.0 % free, cal- 
culated with the equation, are very similar to the 0.2-1.5 % free reported by 
Levy and Yacobi (4) for the rat: 
Ca Kln lPCv  K2n2PCv 
- + (1 )  
1 + K 1 C  F 1 + K 2 C  F 
where C B is the concentration of protein-bound warfarin in nmoles/ml, C r 
is the concentration of free (unbound) warfarin in nmoles/ml, K 1 and K 2 
are the association constants in liters/mole, n 1 and n 2 are the binding capac- 
ities, and P is the concentration of serum albumin in nmoles/ml. Division of 
the top and bottom of the right-hand sides by K 1 and K 2, respectively, and 
substitution of Wosilait's values of K 1 = 0.089 ml/nmole (corresponding 
to 8.94 x 104 liters/mole), K a = 0.0067 ml/nmole (corresponding to 
6.7 x 103 liters/mole), n I = 2, n 2 = 4, and P = 580 nmole/ml gave 
1 t 60Cv 2320C F 
C B - + (2) 
11.24 + C F 149.25 + C F 
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by 
If the total plasma concentration is represented by Cp, then Cp is given 
1160C v 2320C e 
Cp = C v + 11.24 + C e + 149.25 + C v (3) 
Let 
1160C F 2320C v 
Y = Ce + 11.24 + C e + 149.25 + Cv Cp (4) 
A Hewlett-Packard electronic calculator program was written for the latter 
equation to solve for Cv iteratively from a given value of Cp. Trial values 
of C F were entered until y ~-- 0. The free drug concentrations calculated by 
this method agreed very well with those given by Wosilait in his article. 
The free warfarin concentrations in rat plasma observed in this study, cal- 
culated by the above method, are shown in Table II below the total warfarin 
concentrations. The free drug concentrations varied from 1.0% (when 
Cp = 80.1 #g/ml) to 0.90% (when Cp = 37.6 #g/ml) in our rat studies. Con- 
centrations were interconverted using Cv (nmoles/ml) = 3.24 C F (~g/ml). 
RESULTS 
Table II lists the observed average total plasma and tissue concentrations 
and the calculated free warfarin plasma concentrations. 
Table III lists the ratios of the average tissue concentration to the average 
total plasma concentration. For each tissue, the ratio remained essentially 
constant from 0.0833 hr (5 min) to 4 hr with reasonable small coefficients 
of variation. From the data of Anderson (5), similar ratios were calculated 
and these are shown in Table IV. The liver/plasma and brain/plasma ratios 
calculated from Anderson's data agree very well with those calculated data 
obtained in our study. We observed higher average lung/plasma and heart/ 
plasma ratios than Anderson and a lower spleen/plasma ratio than Anderson. 
However, Anderson's data were much more variable than the data in our 
study, as indicated by the coefficients of variation. Since the dose used by 
Anderson was only 2 mg/kg, and the dose used in our studies was 10 mg/kg, 
and similar ratios were observed in the two studies, it appeared to be un- 
necessary to perform additional tissue studies. The dose range of interest 
was 0-10 mg/kg, and it appeared unlikely that there was a "dose dependency" 
in this range. 
The diffusible form of warfarin is the free (unbound) form in plasma 
water, hence tissue concentrations should really be related to the free (un- 






























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































246 Benya and Wagner 
concentrations are given in Table V. For each tissue, from 0.0833 to 4 hr, 
the ratio remained essentially constant with reasonably small coefficients 
of variation. However, as indicated before, in the concentration range studied, 
free (unbound) warfarin ranged from only 0.90 to 1.0 ~o of total plasma con- 
centrations. This is well within analytical error;  hence, in the case of warfarin 
in the rat, use of total plasma concentrations is satisfactory for the model 
shown in Scheme II. 
Fitting of Total Warfarin Plasma Concentration-Time Data 
The total plasma concentrations listed in Table II were "stripped" 
on semilogarithmic graph paper, using an electronic calculator to calculate 
the least-squares lines. The data were tentatively fitted to the equation 
Cp = 27.83e -s'66t + 54.60e -~176 (5) 
On the basis of these results, the classical interpretation is that the data 
obey the two-compartment open model with rapid intravenous injection : 
No. 2 
N o .  1 I C 




Equations appropriate to this model are given below : 
C o 
_e/~)E(k21 - / ~ )  e -p '  - (k21 - ~ )e  - ' ' ]  (~ 
a = 89 + k2~ + kr + x/(k~2 + k21 + kel) 2 - -  4k2,k~3 
fl = 89 --I- k21 + kel) - ~ / ~ 1 2  + k21 + ke,) 2 - 4k21ke,] 
Equation 6 may also be written as equation 9" 



















































































































































































































































































































































































248 Benya and Wagner 
where 
A = D(k2 ,  - ct)/V,(fl - ~) (10) 
B = D(k2x - fl)/Vl(ct - fl) (11) 
The model  parameters  were estimated from the equat ions 
1/'i = D / C  ~ = D / ( A  + B) (12) 
k21 = (Af t  + Sct) / (A 4- B) (13) 
kel = aft~k21 (14) 
k12 = 0~ + fi - k21 - kel (15) 
Using the values A = 27.83, a = 8.66, B = 54.60, and fl = 0.0942 (by 
compar i son  of  equat ions  5 and 9) and equat ions 13 th rough  15, the prelimin- 
ary estimates k z l  = 5.77, kel = 0.141, and k12 = 2.85 h r - 1  were obtained. 
The p lasma concen t ra t ion- t ime  data  and these prel iminary estimates 
were then used as input  data,  and the data  were fitted to equat ions 6 th rough  
8 using the p rog ra m  N O N L I N  and the IBM 360/67 digital computer .  The 
results of the fitting are shown in Table VI. The fit was excellent. Substi tution 
of the est imated parameters  into equat ion 6 gave equat ion 16. Hence equat ion 
16 is an improvement  over equat ion 5 since the sum of squared deviations is 
lower for equ.ation 16 than for equat ion 5. 
Cp = 29.97e -1~ + 54.73e -~176 (16) 
Table VI. Results of Nonlinear Least-Squares Fitting of Average Total 
Plasma Concentration Data 
Least-squares 
9 Estimated parameter estimate Standard deviation 
klz(hr- 1) 3.45 0.846 
k21(hr- 1) 6.67 1.39 
k~z(hr- 1) 0.147 0.0148 
C~ 84.7 2.68 
Derived parameter Parameter value 
(hr- 1) 10.27 
fl (hr- 1) 0.0953 
V1 (liters/kg) 0.110 
Measures of fit Value 
Sum of squared deviations 7.74 
Coefficient of determination 1.00 
Correlation coefficient for Cp on Cp 0.997 
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Fitting of  Tissue Concentration Data  
Results presented in Table III suggested the plot shown in Fig. 1. In 
Fig. 1, the tissue concentration is plotted against the total plasma concen- 
tration. For each tissue, the data from 5 to 240 min appeared to be linear. 
Extrapolation of the lines and forcing the lines through the origin appeared to 
be justified on the basis of the data in Tables Ill and IV. The data obtained 
at 1 rain after injection were lower than the "line values" since mixing had 
probably not been completed. 
The ratios of average tissue concentration to total plasma concentration 
given in Table III are plotted in Fig. 2. For lung, heart, spleen, and possibly 
brain, the ratios appear to be randomly distributed about the average ("line 
values") drawn in the figure. However, for liver there appear to be definite 
trends in the data. 
On the basis of the above results, the tissue concentration data were 
fitted as follows. 
Approach No. 1 : The total plasma concentrations and the lung, heart, 
spleen, and brain tissue concentrations were simultaneously fitted to equa- 
tions, 7, 8, and 17 through 21 using the data from 0.0833 to 4 hr, the program 
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TOTAL PLASMA CONCENTRATION (/~g/ml) 
Fig. 1. Warfarin tissue concentrations relative to total plasma concen- 
tration. Symbols: 9 liver, slope 4.44; I ,  lung, slope 2.73; x, heart, 
slope 2.33 ; <5, spleen, slope 1.03 ; 0, brain, slope 0.41. 
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Fig. 2. Ratios of average tissue concentrations to total plasma concentration given in 
Table III. 
Plasma:  Cp - COp [(k21 - fl)e -~t  - (k21 - c~)e -~'t] (17) 
e - f l  
Lung: T 1 = B 1 . C p  (18) 
Heart :  T 2 = B 2 . C  p (19) 
Spleen: T 3 = B 3 9 Cp (20) 
Brain: T4 = B4. Cp (21) 
The preliminary estimates of B 1 through B 4 were the slopes of the lines 
drawn in Fig. 1. The preliminary estimates of k12, k z l ,  and kel used were 
the least-squares estimates shown in Table VI. The results of the simul- 
taneous fitting are shown in Table VII and Fig. 3. The fits were excellent. 
The overall coefficient of determination was 0.995 and the overall Corr value 
was 0.991. The standard deviations of the B 1 through B 4 values were very 
small relative to the size of the estimates. Both the univariate and s-plane 
95 ~ confidence intervals of the Bt through B 4 values are perhaps the smallest 
reported to date for biological data. For  example, the univariate 95 ~o con- 
fidence interval for B 1 (lung) was 2.41-3.05 and the s-plane 95 ~ confidence 
interval was 2.08-3.38. The percent deviations of the model-predicted con- 
centrations from the observed concentrations are shown in Table VIII.  
The deviations appeared to be reasonably random. Figure 3 is a Cartesian 
coordinate plot showing the results of the simultaneous fitting of the plasma 
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Table VII. Results of Simultaneous Fitting of Tissue and Total Plasma Concentrations of 
Warfarin in the Rat Following Rapid Intravenous Injection of a i0 mg/kg Dose of Sodium 
Warfarin Equivalent to 9.33 mg Warfarin Acid per Kilogram 
Measures offit 
Estimated Least-squares Standard 
Data parameter estimate deviation r 2 Corr 
k12(hr -1) 2.25 1.32 ] 
k21 (hr -1) 4.65 1.89 
Plasma /s (hr- 1) 0.117 0.0267 [ 0.999 
C O (pg/ml) 79.1 8.44 ) 
Lung B~ 2.73 0.151 0.998 
Heart B 2 2.33 0.131 0.998 
Spleen B 3 1.07 0.0758 0.983 
Brain B 4 0.423 0.0584 0~880 
Derived parameters 
c~ (hr- 1) 6.94 
fl (hr- 1) 0.0786 
V~ (liters/kg) 0.118 
Other measures of fit Value 
Sum of squared observations 2.7 x l0 s 
Sum of squared deviations 1.26 x 103 
Overall coefficient of 
determination 0.995 
Overall correlation coefficient 






concentration data and the tissue concentrations for lung, heart, spleen, and 
brain. The lines drawn through the points are based on equations 17 through 
21 and the least-squares estimates of the parameters shown in Table VII. 
The theoretical line drawn through the liver concentration data in Fig. 3 
is discussed subsequently. 
Approach No. 2: The tissue concentrations of lung, heart, spleen, and 
brain were simultaneously fitted to equations 18 through 21 and Cp was given 
by equation 17. The program NONLIN and the IBM 360/67 digital com- 
puter were used as formerly. The initial estimates used for B 1 through 
B 4 were the slopes of the line shown in Fig. 1. The results of this fitting are 
given in Table IX. The least-squares estimates of the proportionality con- 
stants, B 1 through B,, obtained by Approach No. 1 and Approach No. 2 
are identical, as can be seen by comparing the estimates in Tables VII and IX. 
The simultaneous fit by Approach No. 2 was also excellent as seen by the 
measures of fit and low values of the standard deviations and 95 % confidence 
intervals of the parameters shown in Table IX. 
Fitting of Liver Concentration Data 
Figure 2 indicates that unlike for the other tissues measured the liver 
concentration/plasma concentration ratio does not appear to be constant. 
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Fig. 3. Line through liver concentrations is based on equation 
(21): L = 102e -3"66t -k- 212e -~176 Lines through other tissue 
and plasma concentrations are based on simultaneous com- 
puter fitting (Table VII), resulting in the following equations: 
lung concentration = 2.73Cp, heart concentration = 2.33CF, 
spleen concentration = 1.07Cp; brain concentration = 0.423Cp; 
C p =  52.73e-~176 + 26.34e -6"94t, where Cp is the total 
plasma concentration. 
The liver concentration data were separately fitted to a double exponential 
equation using the program N O N L I N  and the IBM 360/67 digital computer. 
The least-squares equation obtained is given as equation 22: 
L = 102e  - s ' 6 6 t  + 212e -~176 (22) 
where f_, is the estimated liver concentration in/~g/g and t is time in hours. 
The fit was excellent with r:  = 1.000, Corr = 0.997, YL 2 = 3.56 • 105, 
and E(L - L) 2 = 40.2. The line drawn through the liver concentration points 
in Fig. 3 is based on equation 12. 
The ~ value of 3.66 in equation 21 is quite different from the ~ value of 
10.27 obtained in fitting the total plasma concentration data (Table VI) or 
the ~ value of 6.94 obtained in simultaneous fitting of the plasma concen- 
trations and tissue concentrations observed in lung, heart, spleen, and brain 
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Table VIII .  P e r c e n t  D e v i a t i o n s  o f  M o d e l - P r e d i c t e d  C o n c e n t r a t i o n s  (Cp or  ~)  f r o m  O b s e r v e d  
C o n c e n t r a t i o n s  (Cp o r  T) 
P e r c e n t  dev i a t i on"  a t  i n d i c a t e d  t ime  
0.0833 0.25 0.50 1 2 3 4 
C o n c e n t r a t i o n  (hr) (hr) (hr) (hr) (hr) (hr) (hr) 
P l a s m a  0.85 - 0.43 0.24 - 1.5 - 4.7 4.4 2.4 
L u n g  3.2 1.5 - 2.8 - 0.65 - 9.4 3.8 3.8 
H e a r t  - 1.5 - 6 . 4  6.6 7.6 - 2 . 7  4.1 - 3 . 8  
Spleen  - 9.0 14.1 18.3 - 2.9 4.6 - 22.3 8.8 
B r a i n  - 14.1 35.5 - 36.6 - 15.4 87.0 116.0 - -  
~For  p l a s m a ,  p e r c e n t  d e v i a t i o n  = [ ( C e -  Cp)/Cp~ x 100. F o r  t issue,  pe r cen t  d e v i a t i o n  
= [ ( ~ -  r)/r] x 100. 
(Table VII). Similarly the/~ value (0.0257) in equation 21 is quite different 
from the fl value of 0.0953 obtained in fitting the total plasma concentration 
data (Table VI) or the fl value of 0.0786 obtained in the simultaneous fitting 
(Table VII). These results and mass balance considerations strongly suggest 
that metabolites were being measured in liver as well as unchanged drug. 
DISCUSSION 
The data and the analyses suggest that the model for warfarin in the rat 
may be written as in Scheme II : 
The reversible arrows between liver and plasma, lung and plasma, etc., 
suggest that equilibration has been achieved within a few minutes after 
injection into the plasma and that individual tissue levels and plasma levels 
within the dashed line are always directly proportional (i.e., binding is 
linear). The lack of direct proportionality between observed liver concen- 
trations and plasma concentrations is attributed to measurement of metabo- 
lites along with unchanged drug when the liver tissue was analyzed, but it is 
assumed that proportionality would have existed if only unchanged drug 
had been measured directly. The portion enclosed by the dashed line in 
Scheme II is conceived of as "compartment No. 1" of the two-compartment 
open model. There may also be tissues other than those measured in this 
compartment. The compartment represented as the solid line circle at the 
top of the scheme is conceived of as "compartment No. 2" of the two- 
compartment open model. The first-order rate constants, k12 and k21, 
are distribution rate constants for free (unbound) warfarin in plasma water 
and other body fluids. The "other fluids" are most likely what is termed 
"interstitial lymph," which averages 12 % of body weight and 20 % of body 
water (6). Other tissues are probably part of compartment 2, also. 
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Table IX. Results of Simultaneous Fitting of Tissue Concentrations of Warfarin in the Lung, 
Heart, Spleen, and Brain of the Rat Following Rapid Intravenous Injection of a 10 mg/kg 
Dose of Sodium Warfarin Equivalent to 9.33 mg Warfarin Acid per Kilogram a 
Proportionality constant (Bi) 
Least- 95 ~ confidence intervals Measures of fit 
squares Standard 
Tissue Parameter estimate deviation Univariate s-Plane r 2 Corr 
Lung B 1 2.73 0.0564 2.61-2.84 2.54-2.92 0.999 0.978 
Heart B 2 2.33 0.0564 2.21-2.44 2.14-2.52 0.996 0.949 
Spleen B 3 1.07 0.0564 0.949-1.18 0.876-1.25 0.982 0.793 
Brain B 4 0.424 0.0587 0.302-0.545 0.227-0.621 0.885 0.747 
Overall 0.995 0.990 
aY, obs2 = 2.55 • 105; ~" dev  2 =  1.31 • 10 a. 
Wosi lai t  (3) stated : "Extensive b ind ing  of a drug by serum a lbumin  is 
thought  to reduce both  the rate of d is t r ibut ion of the drug and its e l iminat ion  
from the body"  and  cited B. B. Brodie as a reference. Warfar in  was 99.0-99.1% 
b o u n d  to p lasma a lbumin  of the rat  in these studies, bu t  it was shown that  
within 1 min  after in t ravenous  inject ion the major  fraction of the dose was 
b o u n d  to tissues. F r o m  5 to 240 min  following injection, it was shown that  
the major  fraction of the dose could be accounted  for in just  five tissues. 
No, 2 
No. 1 
/ . . . .  
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It may be assumed that the drug which is tissue bound is at least as un- 
available for elimination as is the drug which is bound to albumin. Hence 
these data strongly suggest that binding of warfarin to serum albumin does 
not reduce the rate of distribution to any appreciable degree. 
Wosilait (3) stated: "The warfarin in the [rat] plasma was not metabo- 
lized to any great extent." This supports the assumption made that the war- 
farin measured in plasma in this study was unchanged warfarin. The assay 
used was the same as that used by Welling et al. (1), who showed that it gave 
the same results as obtained by a thin-layer chromatographic assay, when 
93 human plasma samples containing warfarin were assayed by both methods. 
Yacobi et al. (7) have recently shown the same for the rat. 
It should be noted that the treatment employed, in which tissue con- 
centrations have been related to total plasma concentrations, was feasible 
only with warfarin since the fraction free in plasma (from 0.009 to 0.01 
in the range of plasma concentrations studied) was essentially constant. If 
free drug concentrations had been used, the B a through B 4 values in Tables 
VII and IX would have been about 100 times greater. 
It should also be noted that for the model shown as Scheme II it is 
implicitly assumed that the diastereoisomers are bound to tissues and plasma 
proteins and metabolized at the same rates. 
Commonly it is assumed that compartment No. 1 of the two-compart- 
ment model is the "plasma compartment"  and compartment No. 2 is the 
"tissue compartment." The results of this study strongly suggest that such a 
description is inadequate. In the case of warfarin in the rat, it may well be 
that the biphasic nature of the plasma concentration curve is principally 
caused by distribution of warfarin between "fluid" compartments. 
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